Delivery Order SPE2DR25D3201-SPE2DR26FT6FF
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award valued at $1,619.64 from the Defense Logistics Agency's Medical Supply Chain on February 2, 2026. This firm fixed-price delivery order, with an ultimate completion date of February 3, 2026, represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively awarded with no...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $6,018.18 on February 2, 2026, by the Defense Logistics Agency's Medical Supply Chain. The contract carries a firm fixed-price structure with an ultimate completion date of February 3, 2026, and represents a non-set-aside competitive award. This delivery order is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,011.99 by the Defense Logistics Agency's Medical Supply Chain on January 12, 2026, with an ultimate completion date of January 13, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,073.06 by the Defense Logistics Agency's Medical Supply Chain on July 14, 2025, with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price delivery order was placed under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $16,067.10 firm fixed-price delivery order from the Defense Logistics Agency's Medical Supply Chain on January 27, 2026, with an ultimate completion date of January 28, 2026. This non-set-aside competitive award represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,754.18 on January 27, 2026, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, which is not set-aside and competitively awarded, is scheduled for completion by January 28, 2026. The award represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency has awarded a delivery order valued at $7,451.89 to AmerisourceBergen Drug Corp for the supply of Jemperli 500 mg/10 mL vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation, due for completion by August 11, 2025. The awardee, headquartered in Conshohocken, Pennsylvania, will perform delivery from its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $66,151.40 by the Defense Logistics Agency's Medical Supply Chain on January 28, 2026. This firm fixed-price delivery order, with an ultimate completion date of January 29, 2026, represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made on a non-set-aside, fully...
- Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,127.28 on January 29, 2026, by the Defense Logistics Agency's Medical Supply Chain. The contract is classified as a firm fixed-price delivery order with an ultimate completion date of January 30, 2026, and utilizes no set-aside designation, indicating it was competitively awarded. This delivery order represents a task order issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,640.00 by the Defense Logistics Agency's Medical Supply Chain on January 29, 2026. This firm fixed-price contract, which is not set-aside and has an ultimate completion date of January 30, 2026, represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- SPE2DR25D3201Indefinite Delivery Contract
- SPE2DR25D3201-SPE2DR26FT6FFDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on February 2, 2026, for Jemperli 500 mg/10 mL vials. This firm fixed-price delivery order, valued at $16,312.56 with a completion date of February 24, 2026, represents a single task order issued under a larger Indefinite Delivery Contract (IDC) vehicle. The award was not set aside for any specific business category and was competitively awarded through open competition, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements. This delivery order falls under AmerisourceBergen's significant $999,999,999 IDC with DLA Troop Support Medical (SPE2DX) through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. The IDC enables the company to supply an extensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities to support Defense Health Agency, U.S. Coast Guard, and other federal government healthcare systems. AmerisourceBergen operates as a subsidiary of parent company Cencora, Inc., which holds the primary IDC relationship with DLA for pharmaceutical distribution services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.3k | 2/1/26 |